Literature DB >> 3050250

Distinguishing minimal-change disease from mesangial disorders.

W A Border1.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3050250     DOI： 10.1038/ki.1988.197

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  26 in total

1.  Is cyclophosphamide effective in patients with IgM-positive minimal change disease?

Authors:  Pavel Geier; Amani Roushdi; Sylva Skálová; Jennifer Vethamuthu; Gabrielle Weiler; Janusz Feber
Journal:  Pediatr Nephrol       Date:  2012-06-24       Impact factor: 3.714

2.  A case of membranoproliferative glomerulonephritis developed over twenty years with three different findings of renal pathology.

Authors:  Yoshikatsu Kaneko; Kazuhiro Yoshita; Hideyuki Kabasawa; Naofumi Imai; Yumi Ito; Mitsuhiro Ueno; Shinichi Nishi; Ichiei Narita
Journal:  CEN Case Rep       Date:  2012-11-09

3.  IgM nephropathy; time to act.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2014-01-01

4.  Basic fibroblast growth factor promotes proliferation of rat glomerular visceral epithelial cells in vitro.

Authors:  A Takeuchi; N Yoshizawa; M Yamamoto; Y Sawasaki; T Oda; A Senoo; H Niwa; Y Fuse
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

5.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

Authors:  T Yamamoto; T Nakamura; N A Noble; E Ruoslahti; W A Border
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

6.  Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

Authors:  Sarah J Swartz; Karen W Eldin; M John Hicks; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2009-02-14       Impact factor: 3.714

7.  Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.

Authors:  D J O'Donoghue; A Darvill; F W Ballardie
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines.

Authors:  J Floege; N Topley; J Hoppe; T B Barrett; K Resch
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

9.  C1q nephropathy and minimal change nephrotic syndrome.

Authors:  Craig S Wong; Christopher A Fink; Jane Baechle; Alexis A Harris; Amy O Staples; John R Brandt
Journal:  Pediatr Nephrol       Date:  2008-12-11       Impact factor: 3.714

Review 10.  Mesangial cells in the pathogenesis of progressive glomerular disease in animal models.

Authors:  J Floege; R J Johnson; W G Couser
Journal:  Clin Investig       Date:  1992-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.